Savannah city leaders to reject state's property tax proposal
SAVANNAH, Ga. (WSAV) – The City of Savannah is publicly rejecting the state's homestead exemption proposal also known as House Bill 581.
The reason being is Savannah and Chatham County homeowners are taxed under the Stephens-Day model, and they said it is better than the state's proposal.
'The new house bill will lock you into a 2024 tax assessment, so if you've had yours locked in for more than a few years, you'd probably want to stay with for a few reasons,' said Savannah realtor Sean Williams of Keller Williams Realty. 'It's going to be a lot cheaper because you've already been locked in for a while, and it also locks in your city taxes not just your county taxes.'
Williams says that way, your city and county taxes will not increase as much as they could under the state's model.
Savannah city leaders, including Mayor Van Johnson and Aldermen, are holding a public forum Tuesday, Jan. 28 at 10 a.m. to hear from homeowners and to explain their position.
Savannah homeowner Bob Rosenwald said he will be in attendance.
'I have a lot of questions,' said Rosenwald, 'and I think what the city needs to do is clarify the issues about Stephens-Day visa-vi 581.'
Rosenwald said he has not made up his mind about what model he prefers, though he has formed an opinion based on his own research.
'I've lived with it for the entire time I've been here, and it's a model that's very good for individuals like me who own a home, but I don't think it's the best thing for the city at large because you're basing home values on many years ago, and inflation is what it is,' said Rosenwald.
Williams sees it differently.
'I think for counties that do not have an exemption already, there is a big pro, it locks your state taxes in place, but for a county like us who has had a Stephens-Day exemption for year, I can't pinpoint what would be an advantage for us,' said Williams.
The city and county have unofficially decided together they will reject the state's exemption.
There will be an official decision made over the course of three public forums, the first being held Tuesday at 10 a.m. at the board of education room at the Eli Whitney Administrative Complex.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
Guided Therapeutics Receives $700,000 Purchase Order and Initial Payment from New Chinese Distributor
PEACHTREE CORNERS, Ga., June 10, 2025--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a purchase order and first payment from Hangzhou Dongye Medical Technology Company Ltd (HDMT) for 35 LuViva systems. HDMT will order directly from Guided Therapeutics and the devices will be assembled and tested by Guided Therapeutics' Chinese partner, Shandong Yaohua Medical Instrument Corporation (SMI). HDMT is in Hangzhou City, Zhejiang Province, where it is the exclusive gynecology products provider for 42 hospitals that perform approximately two million cervical cancer screenings annually. Said Yang Dongye, CEO of HDMT: "We are extremely impressed with the performance of LuViva and our goal is to eventually replace the current screening tests with LuViva." The purchase order for $700,000 is to supply HDMT with 35 systems over the next eight months starting in July of this year. "We are extremely pleased to be working with HDMT to bring LuViva to Zhejiang Province and anticipate making initial shipments next month," added Mark Faupel, Guided Therapeutics' CEO. "Working directly with an exclusive provider of gynecology products that can potentially conduct two million LuViva tests each year is a major advance for GTI." About Guided Therapeutics Guided Therapeutics, Inc. (OTCQB: GTHP) is the maker of a rapid and painless testing platform based on its patented biophotonic technology that utilizes light for the early detection of disease at the cellular level. The Company's first product is the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial with women at risk for cervical disease, the technology was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. For more information, visit: The Guided Therapeutics LuViva® Advanced Cervical Scan is an investigational device and is limited by federal law to investigational use in the U.S. LuViva, the wave logo and "Early detection, better outcomes" are registered trademarks owned by Guided Therapeutics, Inc. Forward-Looking Statements Disclaimer: A number of the matters and subject areas discussed in this news release that are not historical or current facts deal with potential future circumstances and developments. The discussion of such matters and subject areas is qualified by the inherent risks and uncertainties surrounding future expectations generally and also may materially differ from Guided Therapeutics' actual future experience involving any of or more of such matters and subject areas. Such risks and uncertainties include those related to the early stage of commercialization of products, the uncertainty of market acceptance of products, the uncertainty of development or effectiveness of distribution channels, the intense competition in the medical device industry, the sufficiency of capital raised in prior financings and the ability to realize their expected benefits, the uncertainty of future capital to develop products or continue as a going concern, the uncertainty of regulatory approval of products, and the dependence on licensed intellectual property, as well as those that are more fully described from time to time under the heading "Risk Factors" in Guided Therapeutics' reports filed with the SEC, including Guided Therapeutics' Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and subsequent filings. View source version on Contacts Mark FaupelGuided Therapeutics770-242-8723
Yahoo
an hour ago
- Yahoo
Academy Sports and Outdoors, Inc. (ASO) Lags Q1 Earnings and Revenue Estimates
Academy Sports and Outdoors, Inc. (ASO) came out with quarterly earnings of $0.76 per share, missing the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $1.08 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -16.48%. A quarter ago, it was expected that this company would post earnings of $1.82 per share when it actually produced earnings of $1.96, delivering a surprise of 7.69%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Academy Sports and Outdoors , which belongs to the Zacks Leisure and Recreation Products industry, posted revenues of $1.35 billion for the quarter ended April 2025, missing the Zacks Consensus Estimate by 1.37%. This compares to year-ago revenues of $1.36 billion. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Academy Sports and Outdoors shares have lost about 22.9% since the beginning of the year versus the S&P 500's gain of 2.1%. While Academy Sports and Outdoors has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Academy Sports and Outdoors: unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $2.14 on $1.63 billion in revenues for the coming quarter and $6 on $6.15 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Leisure and Recreation Products is currently in the bottom 22% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. LiveOne (LVO), another stock in the broader Zacks Consumer Discretionary sector, has yet to report results for the quarter ended March 2025. The results are expected to be released on June 18. This company is expected to post quarterly loss of $0.05 per share in its upcoming report, which represents a year-over-year change of -66.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. LiveOne's revenues are expected to be $27.86 million, down 9.8% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Academy Sports and Outdoors, Inc. (ASO) : Free Stock Analysis Report LiveOne, Inc. (LVO) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
an hour ago
- Yahoo
Arista 2.0 Strategy Gaining Traction: Is it the Next Key Growth Driver?
Arista Networks, Inc. ANET is aiming to transform itself into Arista 2.0 cloud and data-driven platforms. The company is benefiting from the expanding cloud networking market, which is led by a strong demand for scalable infrastructure. In addition to high capacity and easy availability, its cloud networking solutions promise predictable performance and programmability, enabling integration with third-party applications for network management, automation and Arista 2.0 strategy is resonating well with customers, with its modern networking platforms being foundational for transformation from silos to centers of data. The strategy comprises three components that are likely to drive growth over the next few years. The first component is focused on plans to invest in core businesses by rolling out new solutions and improved AI (artificial intelligence) offerings. Secondly, Arista aims to emphasize more on software-as-a-service for improved revenue visibility. Last but not least, the company plans to enter adjacent markets to target a broader customer boasts a comprehensive portfolio with the right network architecture for client-to-campus data center cloud and AI networking, backed by three guiding principles. These include the best-in-class, highly proactive products with resilience, zero-touch automation and telemetry with predictive client-to-cloud one-click operations with granular visibility and prescriptive insights for deeper AI algorithms. Cisco Systems, Inc. CSCO is the largest player in the networking space. The company has a strong presence in the router and switch market. It has retained a leadership position in WLAN and Ethernet switching and is rapidly expanding its presence in the network security domain. Cisco provides Next-Generation Network Routers that transport data, voice and video information from one IP network to another. It is expanding its Agentic AI footprint with the introduction of Webex AI Agent, Cisco AI Assistant for Webex Contact Center, Workflow Automation in Cisco AI Assistant for Webex, AI Capabilities in Webex Control Hub and Webex Calling Customer Assist. Its strategy of integrating AI across security and collaboration platforms and developing agentic capabilities across the portfolio is a key catalyst for improving customer Networks Inc. JNPR is taking significant steps to enhance the adoption of its AI-Native Networking Platform through the introduction of its Blueprint for AI-Native Acceleration. This comprehensive framework is designed to simplify and accelerate the deployment and utilization of AI-driven networking solutions, benefiting enterprises across various sectors. By leveraging Juniper's AI-Native Networking Platform, organizations can expect up to an 85% reduction in operational expenses and a 90% decrease in network trouble tickets. The platform's industry-leading AIOps technology is key to delivering these results, providing reliable, measurable and secure connections across all devices and applications. The Blueprint for AI-Native Acceleration further enhances these capabilities, enabling customers to achieve up to nine times faster Price Performance, Valuation and EstimatesArista has surged 27.1% over the past year compared with the industry's growth of 36.8% Image Source: Zacks Investment Research From a valuation standpoint, Arista trades at a forward price-to-sales ratio of 13.63, above the industry. Image Source: Zacks Investment Research The Zacks Consensus Estimate for Arista's earnings for 2025 has increased over the past 60 days. Image Source: Zacks Investment Research Arista currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cisco Systems, Inc. (CSCO) : Free Stock Analysis Report Juniper Networks, Inc. (JNPR) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
